Amlan International announces the hiring of Xue as Director of Life Sciences

CHICAGO, IL—Amlan International recently hired Hongyu Xue M.D., Ph.D. as Director of Life Sciences to lead their Vernon Hills, IL-based research team. As an experienced research scientist in clinical and animal nutrition, Xue will direct Amlan’s efforts to develop non-medicated alternatives that enhance intestinal health and function in humans and animals.

With a background in academic medicine and multidisciplinary research that cross-links gastroenterology,  immunology, microbiology, and nutrition, Xue’s research has focused on the therapeutic benefits of dietary supplements in health and disease settings. He has published 15 articles in peer-reviewed journals on dietary pharmaco-nutrients and their effects, many of which have been the subject of invited reviews and major conference presentations.

Most recently, Xue served as a faculty member and Principal Investigator at the University of Colorado where he led multiple preclinical (animal) and clinical (human) trials. He earned his Ph.D. in Oncological Nutrition at the University of Alberta, Canada, where he collaborated with clinical nutrition authority, Vickie Baracos, and his M.D. at the Peking Union Medical School in China.

###

MEDIA CONTACT
Reagan Culbertson
(312) 706-3256
reagan.culbertson@amlan.com

ABOUT AMLAN INTERNATIONAL

Oil-Dri Corporation of America (NYSE: ODC), a Delaware corporation and doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at bioinsightsaml.wpengine.com.

 

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Argentina’s Top Poultry Producers Visit Chicago for Insight on AGP Alternatives

Argentina’s Top Poultry Producers Visit Chicago for Insight on AGP Alternatives

CHICAGO—Argentina’s largest poultry producers and integrators recently traveled to Chicago to gain insight on current production practices and emerging solutions available from the U.S. market. The group, accompanied by representatives from Elanco, the biggest distributor of antibiotics in Argentina, attended a special presentation and discussion about Varium, a new non-antibiotic growth promoter from Amlan International. They also toured the Chicago Board of Trade and Chicago Mercantile Exchange, and gained insight on grain markets from Celina Mesquida, agricultural analyst at RJ O’Brien.

“The group had a lively discussion about trends in poultry production and the changing approach to antibiotic use,” said Dr. Ron Cravens, President of Amlan International, a Nevada Corporation. “Our team was thrilled to share the results of our clinical studies, which show that Varium promotes broiler growth equivalent to antibiotics by reducing the level of pathogens and harmful biotoxins that damage the intestinal lining, stimulating early immune function, and strengthening the intestinal barrier function.”

Elanco serves as Amlan International’s distribution partner in Japan and most countries in Latin America.

###

About Amlan International

Oil-Dri Corporation of America, doing business as Amlan International, helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Amlan International Adds Staff to Accommodate Growth in China

Amlan International Adds Staff to Accommodate Growth in China

SHENZHEN, CHINA—Amlan International announces the addition of three new hires to its China subsidiary, Amlan Trading (Shenzhen) Company, Ltd., keeping pace with growth due to expanding market penetration. The new sales managers were hired to increase service in different regions of China.

Mr. Jixin Dai has taken on the role of Sales Manager of South China. He has over 9 years of experience in the livestock industry, and holds a bachelor degree in Animal Science from China Agricultural University. Dai will help Amlan Trading develop new client relationships in South China while promoting product sales.

Mr. Shengguo Tang joins Amlan Trading as Sales Manager of Central China. Backed by 8 years of experience in the feed industry, Tang will work to further establish a distribution network and increase Amlan Trading’s market share in Central China. He previously held the position of Regional Sales Manager of Novus International Trading (Shanghai) Co, Ltd. and received his Master’s Degree of Animal Nutrition from Hu Nan Agriculture University.

Mr. Quingliang Wu will assume the role of Sales Manager of East China. After his work selling Biomin’s products in East China, Wu comes to Amlan Trading with over 5 years of sales experience in feed additive products. He will be responsible for promoting Amlan product sales in East China. Wu is a graduate of Shanxi Agricultural University with a major in Animal Science.

“We are proud to announce these strategic new hires to support our mission of providing personal technical service across South, Central, and East China,” said Dr. Ron Cravens, President of Amlan International, a Nevada Corporation.

###

About Amlan International

Oil-Dri Corporation of America, doing business as Amlan International, helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Calibrin‐Z Gains OMRI Listed Status, Gives Organic Producers Access to Bacterial Toxin Binder

Calibrin‐Z Gains OMRI Listed Status, Gives Organic Producers Access to Bacterial Toxin Binder

CHICAGO, IL— Calibrin‐Z, which recently became the first product approved for the control of disease‐causing bacterial toxins, has gained listed status from the Organic Materials Review Institute (OMRI). This approval confirms the product can be used in certified organic production according to the USDA National Organic Program Rule.

Calibrin‐Z is a broad spectrum bacterial and fungal toxin adsorbent for use in livestock that has proven in more than 70 clinical studies to reduce effects from a broad spectrum of biotoxins that cause disease such as those produced by Clostridium perfringens, E. coli and Salmonella.

Recently completed work from the USDA demonstrates the ability of the product to control toxins produced by pathogenic bacteria, which are a leading source of economic loss to the global livestock industry.

“As the recently completed clinical research demonstrates, Calibrin‐Z is the only product to control the broadest range of bacterial and fungal toxins, which makes its OMRI Listed status extremely beneficial to organic and conventional producers alike,” said, Dr. Ron Cravens, President, Amlan International.

The Organic Materials Review Institute (OMRI) is a third party institute that provides organic certifiers, growers, manufacturers and suppliers with an independent review of products intended for use in certified organic production, handling and processing.

For more information on Calibrin‐Z, visit www.Amlan.com

###

Amlan International, a division of Oil‐Dri Corporation of America (NYSE: ODC), helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP‐alternative market, driven largely by the research overseen by its laboratory campus in Vernon Hills, IL. In 2014, the company’s global reach expanded with the opening of China operations in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Varium™ Wins Best New Poultry Product Middle East at AgraME Awards

Varium™ Wins Best New Poultry Product Middle East at AgraME Awards

Dubai, UAE—The new non‐antibiotic growth promoter Varium™ was named Best New Poultry Product, Middle East at the AgraME Awards on March 14, 2016 at the Dubai International Convention and Exhibition Centre.

Varium is an innovative formulated feed additive that has been shown in clinical studies to promote growth in poultry equivalent to commonly used antiobiotics. It works by reducing the level of pathogens and harmful biotoxins that damage the intestinal lining, stimulating early immune function, and strengthening the intestinal barrier function.

Acording to AgraME organizers, the award for Best New Product recognizes an exciting new poultry product that “demonstrates a prominent and far‐reaching competitive advantage, meets market needs through demand focus and offers improvements in cost efficiency.” All entered products were scored against key criteria surrounding leadership, features, innovation, performance, benefits, value and sustainability.

Produced by Amlan International, a leader in improving intestinal health in livestock, Varium has been shown to promote broiler growth equivalent to AGPs by reducing the level of pathogens and harmful biotoxins that damage the intestinal lining, strengthening the intestinal barrier function, and stimulating early immune function.

“We’re thrilled that Varium is being recognized for its potential as an AGP replacement and ability to enhance gut health and bird performance,” said Dr. Ron Cravens, President, Amlan International. “In clinical trials, Varium provided a 3:1 return on investment by improving feed conversion and reducing mortality. It also reduced the severity of Clostridium perfringens‐induced necrotic enteritis lesions, providing clear evidence of favorably impacting intestinal health and function.”

More information on Varium can be found at www.Amlan.com and a complete list of AgraME award winners can be found at http://www.agramiddleeast.com.

###

Amlan International, a division of Oil‐Dri Corporation of America (NYSE: ODC), helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP‐alternative market, driven largely by the research overseen by its laboratory campus in Vernon Hills, IL. In 2014, the company’s global reach expanded with the opening of China operations in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Varium™ Approved in Philippines for Necrotic Enteritis Treatment

Varium™ Approved in Philippines for Necrotic Enteritis Treatment

CHICAGO, IL—The Philippines Department of Agriculture, Bureau of Animal Industry recently approved Varium™ as a treatment for necrotic enteritis in poultry and as a tool to improve gut health, categorizing it as a performance enhancer that impacts feed efficiency, weight gain and lesion scores.

Produced by Amlan International, a leader in improving intestinal health in livestock, Varium™ is a unique new non‐antibiotic formulated product that acts like an antibiotic growth promoter (AGP). Results from multiple research studies showed that the product consistently reduced the effects of bacteria‐associated enteric disease, which has been estimated to cost the global poultry industry close to US$6 billion annually.

“In addition to achieving growth performance equivalent to commercial AGPs, Varium has been shown to lower Clostridium perfringens‐induced necrotic enteritis lesion scores, improve feed conversion, reduce mortality and support weight gain,” said Dr. Ron Cravens, President, Amlan International. “In clinical trials, Varium provided a ROI of 3:1 or higher.”

Interest in AGP alternatives that address bird intestinal health while enhancing performance is growing in light of the expanding global shift toward no antibiotics ever poultry production. In clinical studies, Varium promoted broiler growth equivalent to AGPs by reducing the level of pathogens and harmful biotoxins that damage the intestinal lining, stimulating early immune function, and strengthening the intestinal barrier function.

More information on Varium can be found at www.Amlan.com. Watch the video for insight on intestinal health challenges and Varium’s mode of action.

###

About Amlan International

A wholly owned subsidiary of the Oil‐Dri Corporation of America (NYSE: ODC), Amlan International helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP‐alternative market, driven largely by the research overseen by its laboratory campus in Vernon Hills, IL. In 2014, the company’s global reach expanded with the opening of China operations in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

First Product Approved to Control Disease-Causing Bacterial Toxins

First Product Approved to Control Disease-Causing Bacterial Toxins

CHICAGO, IL—Amlan International announces that Calibrin-Z has been approved for use as an intestinal adsorbent for the control of disease-causing bacterial toxins from Argentina’s Ministry of Agriculture. Regulatory approval was granted after a review of Calibrin-Z’s extensive efficacy data, resulting in its status as the first product worldwide recognized to control bacterial toxins produced by pathogenic bacteria such as Clostridium perfringens, E. coli and Salmonella sp.

“Such an approval is a rarity, especially in such a challenging regulatory environment,” said Dr. Ron Cravens, President, Amlan International. “As the livestock industry continues to move away from using antibiotics as growth promoters, producers are beginning to realize the economic impact of toxins produced by pathogenic bacteria. Bacterial toxins cause notably greater economic loss to the global livestock industry than do mycotoxins and Calibrin-Z is positioned to offer an added level of proven protection for animals challenged with enteric diseases.”

More than 70 clinical studies and recent work from the USDA, demonstrate the product’s ability to adsorb bacterial toxins thereby reducing the effects of enteric diseases—a major source of economic loss in the livestock industry. The regulatory approval for Calibrin-Z is for poultry, swine, and cattle.

For more information on Calibrin-Z, visit www.Amlan.com

###

About Amlan International

A wholly owned subsidiary of the Oil-Dri Corporation of America (NYSE: ODC), Amlan International helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product to include alternatives to antibiotic growth promoters that improve intestinal health and function. Innovative research is conducted at its laboratory campus in Vernon Hills, IL. In 2014, the company’s global reach expanded with the opening of operations in Shenzhen, China. Further information on Amlan International is available at Amlan.com.

Amlan–Productivity for Life.

The product discussed here may not be available for sale and/or may not be registered and available in all countries where Amlan International is represented.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Amlan International Launches NeoPrime™ to Improve Performance in Nursery Pigs

Amlan International Launches NeoPrime™ to Improve Performance in Nursery Pigs

CHICAGO, IL— Amlan International announces the launch of NeoPrime™, a new intestinal and immunity primer for weaning and post-weaning piglets. In clinical and farm usage studies, NeoPrime consistently delivered the equivalent of 5% more pig at finish due to combined improvements in feed conversion and weight gain.

Its unique formula improves post-weaning performance by reducing the level of pathogenic bacteria and biotoxins from the intestines, energizing and strengthening the cells that form the intestinal barrier, and stimulating passive and active immunities for the defense against pathogens.

“We know that intestinal health is essential for efficient conversion of feed to gain. The first phases of feeding are the most stressful for pigs, which can slow the development of a healthy intestinal environment and immune function,” said Dr. Ron Cravens, President, Amlan International. “NeoPrime is focused on getting pigs off to a strong start for a lifetime of good production.”

In addition to aiding in the digestion and absorption of nutrients, the intestinal environment forms a pig’s first line of defense against the harmful bacterial and fungal biotoxins, bacteria, or feed-associated antigens that can cause diarrhea, mal-absorption, and reduced growth and production.

Stressors surrounding the weaning period, such as separation from the sow, transition to dry food, and increased exposure to pathogens, are known to contribute to intestinal and immune dysfunctions that represent a major source of production losses in swine operations.

“Intestinal damage incurred during the post-weaning period can take as many as fifteen days to fully recover,” said Cravens. “NeoPrime works to stem this damage, and as a result we’ve seen farms with improvements in feed conversion and weight gain of 7.5% and 13.6% respectively.”

NeoPrime is currently approved for use in Japan, Thailand and the Philippines, and is waiting registration approval in multiple other countries in South America and the Asia-Pacific region.

###

Amlan International, a division of Oil-Dri Corporation of America (NYSE: ODC), helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research overseen by its

laboratory campus in Vernon Hills, IL. In 2014, the company’s global reach expanded with the opening of China operations in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Amlan International Launches AGP Alternative, Varium™

Amlan International Launches AGP Alternative, Varium™

 

CHICAGO, IL— Amlan International announces the launch of Varium™, a new non-antibiotic formulated product that acts like an antibiotic growth promoter (AGP) for poultry. In clinical studies Varium promotes broiler growth equivalent to antibiotics by reducing the level of pathogens and harmful biotoxins that damage the intestinal lining, stimulating early immune function, and strengthening the intestinal barrier function.

“Research studies conducted with leading poultry collaborators in the U.S. showed that Varium consistently achieved growth performance equivalent to commercial AGPs and also reduced the effects of bacteria-associated enteric disease,” said Dr. Ron Cravens, President, Amlan International.

As the global poultry production community continues to shift to a no antibiotics ever approach in light of consumer and regulatory pressures, such as the FDA’s Veterinary Feed Directive, interest in AGP alternatives that address bird intestinal health while enhancing performance is growing.

Biotoxins produced by microorganisms such as Clostridium perfringens, E. coli, and Salmonella sp. damage the intestinal barrier, which reduces overall gut health and function thereby diverting energy from weight gain. Decreased gut function can also cause birds to suffer from lower feed conversion and increased mortality. By focusing on maintaining a healthy intestinal environment, producers are able to maximize the efficiency of their nutritional program.

“Varium has been shown to lower Clostridium perfringens induced Necrotic Enteritis lesion scores, improve feed conversion, reduce mortality and support weight gain,” said Cravens. “In fact, in clinical trials, Varium provided a ROI of 3:1 or higher by improving feed conversion and decreasing mortality.”

Varium is currently approved for use in Bolivia, Malaysia, Peru, the Philippines and Thailand, and is waiting registration approval in multiple other countries in South America, the Middle East and the Asia-Pacific region. For more information visit www.Amlan.com

 

###

About Amlan International

A wholly owned subsidiary of the Oil-Dri Corporation of America (NYSE: ODC), Amlan International helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2014, the company’s global reach expanded with the opening of China operations in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube